NAD+ Subcutaneous Pen at Home: Clinical Insight Into a New Era of Cellular Therapy
The evolution of modern aesthetic and regenerative medicine, which converges cutting-edge biochemistry with patient-led convenience, is driving a significant shift in how we approach ageing, recovery, and cognitive support. Among the most promising areas of interest is nicotinamide adenine dinucleotide, more commonly known as NAD+. Once the focus of laboratory researchers and biohackers, NAD+ is now finding its place within clinical practice, particularly in the context of metabolic support, neurological resilience, and mitochondrial optimisation.
In our clinic, we recognise the increasing demand for evidence-informed, self-directed therapeutic options that align with modern lifestyles. One such option is the NAD+ SC Pen, a subcutaneous self-injection system designed to deliver bioavailable NAD+ in precise, clinically relevant doses. It offers a compelling alternative to traditional intravenous infusions, without compromising efficacy or safety. In this article, we’ll explore the scientific rationale, biochemical pathways, and clinical implications of NAD+ supplementation, with particular attention to the use of self-administered subcutaneous therapy in a home setting.
Understanding NAD+: A Core Metabolite in Human Health
NAD+ is a pyridine nucleotide derived from vitamin B3 (niacin, nicotinamide or nicotinic acid), and it serves a fundamental role in redox reactions, acting as a hydride acceptor in oxidative metabolism. It functions as a coenzyme for several classes of enzymes, most notably sirtuins, PARPs (poly(ADP-ribose) polymerases), and CD38, all of which are involved in essential processes such as DNA repair, epigenetic regulation, cellular stress responses, and circadian rhythm maintenance.
In the context of cellular metabolism, nicotinamide adenine dinucleotide (NAD+) facilitates electron transfer during the mitochondrial respiratory chain, enabling oxidative phosphorylation and adenosine triphosphate (ATP) generation. Inadequate NAD+ availability can lead to mitochondrial dysfunction, energy deficits, and an accumulation of oxidative stress, all of which are associated with intrinsic and extrinsic ageing processes.
Moreover, NAD+ has a direct role in modulating immune responses, maintaining genomic stability, and facilitating autophagy and proteostasis. Depletion of NAD+ has been observed in a wide range of pathologies, including metabolic syndrome, type 2 diabetes, neurodegenerative disorders (such as Alzheimer’s and Parkinson’s disease), chronic fatigue syndrome, and even depression.
Ageing and the Decline of NAD+
One of the most striking findings in recent metabolic research is the progressive decline of NAD+ concentrations with age. By middle age, NAD+ levels may be reduced by as much as 50% compared to youth, and this loss is strongly associated with mitochondrial decline, genomic instability, and increased systemic inflammation (so-called “inflammaging”).
This age-related NAD+ depletion appears to be multifactorial: increased consumption via activated CD38 and PARP enzymes (particularly in response to DNA damage), decreased biosynthesis through the Preiss-Handler and salvage pathways, and reduced efficiency of the rate-limiting enzyme NAMPT. The result is a metabolic environment that favours cellular senescence, impaired resilience, and tissue degeneration.
Clinical Potential of NAD+ Repletion
Restoring NAD+ levels through exogenous supplementation has gained interest in clinical and aesthetic medicine due to its multi-system effects. While research is ongoing, early-stage trials and preclinical models suggest benefits in areas such as metabolic function, neuroplasticity, sleep regulation, and even dermal rejuvenation.
In neurocognitive applications, NAD+ appears to promote neuronal health by enhancing mitochondrial biogenesis and synaptic plasticity. This could offer a neuroprotective effect for patients with mild cognitive impairment or age-related cognitive decline. Some studies have shown that NAD+ therapy can improve working memory, reduce brain fog, and enhance concentration, especially in individuals with high oxidative stress or chronic fatigue.
In terms of systemic energy metabolism, NAD+ has been shown to improve insulin sensitivity and promote fatty acid oxidation. These effects are partly mediated through sirtuin activation and AMPK signalling, both of which play a role in cellular energy homeostasis and the regulation of inflammatory markers. For patients struggling with metabolic syndrome or insulin resistance, NAD+ support may represent a valuable adjunct.
From a dermatological perspective, NAD+ supplementation has shown promise in improving skin hydration, barrier function, and cellular turnover. This may be due to improved mitochondrial energy production and enhanced cellular repair mechanisms. Although it is not a substitute for retinoids or procedural aesthetics, NAD+ supplementation can be used in conjunction with them in holistic anti-ageing protocols.
Ready to Make a Change?
Please click a one of the buttons on the right to see all of our treatments and what conditions they treat.
Why Subcutaneous Delivery?
Intravenous (IV) administration has traditionally been the gold standard for delivering high concentrations of NAD+ systemically. However, it requires in-clinic administration, professional supervision, and can involve lengthy infusion times (often 2–4 hours per session). While effective, it poses logistical and financial barriers for many patients.
Although oral supplementation is convenient, it suffers from limited and variable bioavailability. Supplements are often in the form of precursors, such as nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN). First-pass metabolism in the liver significantly reduces the amount of active nicotinamide adenine dinucleotide (NAD+) that reaches the systemic circulation, and there is high interindividual variability.
Subcutaneous (SC) injection offers a middle ground: bypassing hepatic degradation, allowing gradual absorption into the lymphatic and vascular systems, and enabling relatively high bioavailability without the need for clinical administration. It also facilitates micro-dosing, which can support more consistent NAD+ plasma levels over time.
The NAD Plus SC Pen is engineered to deliver precise, titratable doses of NAD+ into the subcutaneous tissue, using a spring-loaded, ultra-fine needle system. Designed for patient-led administration, it prioritises ease of use, sterility, and safety. The pen is CE-certified and meets UK medical device standards.
Dosing, Absorption and Pharmacokinetics
Typical starting protocols involve subcutaneous doses ranging from 50mg to 100mg administered 1–3 times per week, depending on patient need, clinical objectives, and tolerability. Titration should be gradual to reduce the risk of transient side effects, such as flushing, dizziness, or mild gastrointestinal discomfort.
NAD+ has a relatively short half-life in circulation, but its metabolic impact extends well beyond plasma concentrations. Once absorbed, NAD+ is quickly taken up by tissues and utilised in intracellular pathways. Many practitioners favour a “low and slow” approach, enabling the body to adjust to increasing NAD+ availability while avoiding abrupt metabolic shifts.
Based on our experience, patients typically notice subjective improvements within one to four weeks. These improvements include better energy regulation, reduced mental fatigue, and enhanced sleep quality. Quantitative biomarkers, such as fasting glucose, inflammatory markers, and lipid profiles, may demonstrate improvement after 8–12 weeks of consistent therapy.
Safety and Contraindications
Typical starting protocols involve subcutaneous doses ranging from 50mg to 100mg administered 1–3 times per week, depending on patient need, clinical objectives, and tolerability. Titration should be gradual to reduce the risk of transient side effects, such as flushing, dizziness, or mild gastrointestinal discomfort.
NAD+ has a relatively short half-life in circulation, but its metabolic impact extends well beyond plasma concentrations. Once absorbed, NAD+ is quickly taken up by tissues and utilised in intracellular pathways. Many practitioners favour a “low and slow” approach, enabling the body to adjust to increasing NAD+ availability while avoiding abrupt metabolic shifts.
Based on our experience, patients typically notice subjective improvements within one to four weeks. These improvements include better energy regulation, reduced mental fatigue, and enhanced sleep quality. Quantitative biomarkers, such as fasting glucose, inflammatory markers, and lipid profiles, may demonstrate improvement after 8–12 weeks of consistent therapy.
The Role of NAD+ in Aesthetic and Integrative Practice
At Perpetual Aesthetics, we integrate NAD+ therapy not as a standalone solution, but as part of a broader strategy for patient wellbeing. We believe optimal outcomes occur when biochemical replenishment is combined with lifestyle modification, micronutrient support, and personalised aesthetic care.
For patients pursuing facial rejuvenation, NAD+ may be used to support post-procedural recovery or enhance tissue resilience. In body contouring contexts, it may improve energy availability and support metabolic goals. And for those managing high-stress lives, poor sleep, or mental burnout, NAD+ may assist in rebalancing neurochemical function and mood regulation.
The NAD Plus SC Pen allows us to extend these benefits beyond the clinic, offering patients a way to maintain consistency and control in their wellness routines. We provide thorough onboarding, education, and support, ensuring patients feel confident in managing their therapy.
Looking Ahead: The Future of Self-Administered Biotherapeutics
As patient autonomy continues to rise, we expect self-directed injectables like the NAD+ SC Pen to play a growing role in the delivery of personalised medicine. Advances in transdermal, intranasal, and subcutaneous delivery systems are already transforming the accessibility of treatments previously confined to specialist clinics.
In the field of aesthetic medicine, where beauty is increasingly seen as a sign of inner health, NAD+ creates a strong link between functional and cosmetic results. Whether used to boost energy, improve cognitive function, promote skin health, or enhance cellular resilience, NAD+ is a valuable addition to any progressive wellness regimen.
For those considering NAD+ therapy, we encourage a holistic assessment that includes medical history, lifestyle evaluation, and realistic expectations. As with any therapy, it is not a panacea, but it may serve as a powerful catalyst.
At Perpetual Aesthetics, we remain committed to evidence-based practice, ongoing research, and patient-centred innovation. The NAD Plus SC Pen is one of many tools we offer to help patients feel, look, and live their best.
To learn more about how NAD+ therapy might fit into your health or aesthetic plan, contact us for a personalised consultation or explore our online resources.
________________________________________
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified medical professional before beginning any new treatment.
Ready to Make a Change?
Please click a one of the buttons on the right to see all of our treatments and what conditions they treat.